|Tested species reactivity||Chemical|
|Published species reactivity||Not Applicable|
|Host / Isotype||Mouse / IgG|
|Storage buffer||PBS, pH 7.2|
|Contains||5mM sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (IHC)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (Paraffin) (IHC (P))||See 2 publications below|
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) is a synthetic nucleoside that is an analogue of thymidine. BrdU is commonly used in the detection of proliferating cells in living tissues. BrdU can be incorporated into the newly synthesized DNA of replicating cells (during the S phase of the cell cycle), substituting for thymidine during DNA replication. Antibodies specific for BrdU can then be used to detect the incorporated chemical, thus indicating cells that were actively replicating their DNA. Binding of the antibody requires denaturation of the DNA, usually by exposing the cells to acid or heat.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Delta-9-tetrahydrocannabinol disrupts hippocampal neuroplasticity and neurogenesis in trained, but not untrained adolescent Sprague-Dawley rats.
B35138 was used in immunohistochemistry - paraffin section to identify effects of Delta(9)-tetrahydrocannabinol on the early induction of adaptive processes that support learning
|Steel RW,Miller JH,Sim DA,Day DJ||Brain research (1548:12)||2014|
|Not Applicable||Not Cited||
A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth.
B35138 was used in immunohistochemistry - paraffin section to elucidate decreased chondrocyte proliferation caused by chronic ER stress as a key factor in reduced bone growth in a novel transgenic mouse model of growth plate dysplasia
|Gualeni B,Rajpar MH,Kellogg A,Bell PA,Arvan P,Boot-Handford RP,Briggs MD||Disease models and mechanisms (6:1414)||2013|